Advances in Targeted Therapy and Immunotherapy Driving the North America Liver Cancer Therapeutics Market
North America continues to lead the liver cancer therapeutics landscape owing to its well-established healthcare infrastructure, growing adoption of advanced cancer therapies, and substantial investments in pharmaceutical research and development. Rising awareness of early diagnosis, increasing prevalence of liver cancer risk factors such as hepatitis infections and non-alcoholic fatty...
0 Комментарии 0 Поделились 40 Просмотры 0 предпросмотр